AndroGel Lawsuits Moving Forward

In this article, Laurence Banville comments on recent AndroGel Lawsuit pretrial proceedings. Attorneys involved in the nationwide testosterone lawsuit MDL have indicated that things are moving forward during pretrial proceedings. In just two days, on October 15th, 2015, the next Case Management Conference is scheduled to take place. This meeting is set for 3:30 p.m., and is said to involve the presentation of a Discovery Schedule by counsel, which is to have been previously agreed upon by all involved parties, as reported by court documents.

The Lawsuits

AndroGel Lawsuit Pretrial Moving Forward MDL 2545 lawsuits contain many of the same allegations from men across the country who have used some form of testosterone drug. The complaints allege that manufacturers of these drugs failed to provide proper warnings on the product labels. Additionally, allegations connect use of the drugs to serious health issues such as blood clots, strokes, heart attacks, and even death. Finally, the complaints state that testosterone treatment manufacturers used misleading and aggressive advertising in order to increase product sales.

What Is Low T?

As men age, the testosterone level in their bodies naturally lowers. This can cause some unpleasant side effects, including lowered libido, a decrease in bone and muscle mass, and an increase in weight, fatigue, and irritability. Many of these men turn to low t drugs in order to combat these symptoms. Low t drugs, however, were not approved by the FDA for this purpose, but were instead intended for men with exceptionally low levels of testosterone and a diagnosed condition called hypogonadism. Plaintiffs allege that specific, manipulative marketing targeted men without hypogonadism, who were experiencing the normal side effects of aging, and made them feel as if they had a fabricated condition called “low t.” Manufacturers of AndroGel, the most popular of the low testosterone drug treatments, made over $1 billion in 2013 alone.

Details on AndroGel Litigation

MDL 2545 is being presided over by Judge Matthew Kennelly in Chicago, Illinois. The lawsuits involved currently number over 2,000, and Bellwether trials are set to begin in 2016. The lawyers of the defendants and plaintiffs currently have until the end of October to choose 32 cases for these initial bellwether trials, whose topics will involve blood clots and heart attacks. Laurence Banville, Esq. of Banville Law commented on the importance of these trials. “This trial selection is going to be an important part of the pending litigation, and the outcomes will set the pace for the remaining MDL, assisting both the defendants and plaintiffs in making critical decisions moving forward,” he shared. Banville is currently assisting individuals who are looking to potentially join the multidistrict litigation concerning testosterone drugs. Additionally, he sponsors, which is an online resource designed to provide current information on the topic.

Contact Us To Explore Your Rights

If you or someone you love have suffered from health problems after using a low testosterone drug, you may be entitled to compensation. Reach out to Laurence Banville, Esq. directly with any questions, or to explore your rights by contacting him at 917-809-6595.

About Laurence Banville

Attorney Contributor:

Laurence P. Banville, Esq. is the managing partner of Banville Law. He is a regular contributor on several topics including negligent security cases, child sexual abuse and Dram Shop and liquor liability cases.

This article was fact checked prior to publishing by this author to ensure compliance with our rigorous editorial standards. We will only use authoritative sources. Our values compel us to provide only trustworthy information. If you find an error, please contact us.

View All Posts